Tom Shannon

About

Tom Shannon is a leading figure in urologic oncology, with a research focus on optimizing surgical outcomes for prostate cancer patients. His work centers on the intersection of minimally invasive surgical techniques, including laparoscopic and robot-assisted radical prostatectomy, and patient-specific risk factors. Shannon’s most impactful study, "Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer" (2020, 32 citations), demonstrates his commitment to improving surgical candidacy and recovery through preoperative intervention. This work highlights a novel, holistic approach to enhancing surgical outcomes in a challenging patient population. Additionally, his analysis of the Australian laparoscopic non-robotic radical prostatectomy experience, encompassing 2,943 cases, provides critical, large-scale data on the efficacy and safety of high-volume, fellowship-trained surgeons. This contribution has helped establish benchmarks for surgical quality and training in Australia. Through these studies, Shannon has advanced the evidence base for both preoperative optimization and surgical technique, directly impacting clinical practice and patient care in prostate cancer management.

Research Focus

Key Achievements

Top Papers

1. 1
   Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer

   32 citations · 2020
2. 2
   The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases ( <scp>USANZ</scp> supplement)

   12 citations · 2016

Key Collaborators

Contact & Links